Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2025-12-25 @ 12:33 PM
NCT ID: NCT02605395
Description: All subject population was used for analysis.
Frequency Threshold: 0
Time Frame: From start of study treatment up to end of the follow-up (24 hours post last blood sample collected for Period 2; Up to 10 days)
Study: NCT02605395
Study Brief: Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Idiazole 20 mg Eligible participants received a single oral dose of Idiazole 20 mg enteric coated tablets under fed condition in treatment period 1 or 2. 0 None 0 70 0 70 View
Pariet 20 mg Eligible participants received a single dose of Pariet 20 mg gastro-resistant tablets under fed condition in treatment period 1 or 2. 0 None 0 70 0 70 View
Serious Events(If Any):
Other Events(If Any):